In this webinar, there were case study presentations from three top sarcoma institutions that demonstrate the value of biomarker testing. A Question & Answer session followed the presentations.
Here are some #GISTWishes from our LRG Community shared in our December 2021 newsletter.
Dr. George Demetri of the Dana-Farber Cancer Institute presented “In the Beginning…The Story of How GIST Treatments Began”.
Dr. Shruti Bhargava, University of California San Diego, presented SDH-deficient GIST Research Updates at New Horizons 2021.
Chuck Korte presented his story as Long-term GIST Survivor at New Horizons 2021.
Dr. Sameer Rastogi and Dr. Yoon-Koo Kang presented "Global Access to Treatment" at New Horizons 2021.
Giora Sharf and Norman Scherzer presented "Lessons Learned from the GIST & CML Community" at New Horizons 2021.
Dr. Ciara Kelly, Dr. Suzanne George, and Dr. Bruno Vincenzi presented GIST Research Updates at New Horizons 2021.
Sarah McGoram, Carolina Goič, Florence Thwagi, Tania Carolina Diaz presented Best Practices: How to Advocate for Better Access at New Horizons 2021.
Dr. David Josephy and Jim Hughes presented "Clinical Trials 2000-2021" at New Horizons 2021.
